Lv2
110 积分 2024-11-30 加入
Clinical benefit, price and epidemiology of orphan drugs approved in China: a cross-sectional analysis of orphan drug policy (ODP) in China
20天前
已关闭
Pathing the way from regulatory approval to market access for gene therapy products (GTPs): An integrative review in the US, EU5, Japan and China
1个月前
已完结
The evolving regulatory system of advanced therapy medicinal products in China: a documentary analysis using the World Health Organization Global Benchmarking Tool standards
1个月前
已完结
Digital health interventions for psychological outcomes among adolescents and young adults with cancer: a systematic review and meta-analysis
1个月前
已完结
National value-based pricing negotiation for oncology drugs — lessons from China
1个月前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
10个月前
已完结
OX40–heparan sulfate binding facilitates CAR T cell penetration into solid tumors in mice
10个月前
已完结
BCMA-BBZ-OX40 CAR-T Therapy Using an Instant Manufacturing Platform in Multiple Myeloma
10个月前
已完结
皖公网安备34019202002308
